nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—ABCB1—colon cancer	0.257	1	CbGaD
Imipramine—SLC22A3—Irinotecan—colon cancer	0.117	0.243	CbGbCtD
Imipramine—SLC22A3—Vincristine—colon cancer	0.102	0.212	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0377	0.0783	CbGbCtD
Imipramine—CYP3A7—Irinotecan—colon cancer	0.0377	0.0783	CbGbCtD
Imipramine—CYP2B6—Irinotecan—colon cancer	0.0359	0.0746	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0329	0.0685	CbGbCtD
Imipramine—CYP3A7—Vincristine—colon cancer	0.0329	0.0685	CbGbCtD
Imipramine—CYP1A2—Fluorouracil—colon cancer	0.0202	0.042	CbGbCtD
Imipramine—ABCB1—Irinotecan—colon cancer	0.0184	0.0382	CbGbCtD
Imipramine—ABCB1—Vincristine—colon cancer	0.0161	0.0334	CbGbCtD
Imipramine—CYP3A4—Irinotecan—colon cancer	0.011	0.0229	CbGbCtD
Imipramine—ABCB1—Methotrexate—colon cancer	0.00974	0.0202	CbGbCtD
Imipramine—CYP3A4—Vincristine—colon cancer	0.00964	0.02	CbGbCtD
Imipramine—CHRM3—ureter—colon cancer	0.00887	0.0894	CbGeAlD
Imipramine—HTR7—myenteric nerve plexus—colon cancer	0.00727	0.0733	CbGeAlD
Imipramine—ORM1—bile—colon cancer	0.00697	0.0703	CbGeAlD
Imipramine—CHRM3—muscle of abdomen—colon cancer	0.00638	0.0644	CbGeAlD
Imipramine—HTR7—vein—colon cancer	0.00468	0.0472	CbGeAlD
Imipramine—HTR2A—myenteric nerve plexus—colon cancer	0.00453	0.0457	CbGeAlD
Imipramine—HTR2A—vein—colon cancer	0.00292	0.0295	CbGeAlD
Imipramine—ORM1—gall bladder—colon cancer	0.00193	0.0195	CbGeAlD
Imipramine—HTR7—endothelium—colon cancer	0.00161	0.0163	CbGeAlD
Imipramine—HTR7—blood vessel—colon cancer	0.00149	0.015	CbGeAlD
Imipramine—CHRM5—epithelium—colon cancer	0.00136	0.0137	CbGeAlD
Imipramine—CYP2C18—digestive system—colon cancer	0.00126	0.0128	CbGeAlD
Imipramine—ADRA1D—epithelium—colon cancer	0.00121	0.0123	CbGeAlD
Imipramine—SLC22A2—renal system—colon cancer	0.0012	0.0121	CbGeAlD
Imipramine—ADRA1B—renal system—colon cancer	0.00115	0.0116	CbGeAlD
Imipramine—CYP2C18—vagina—colon cancer	0.00112	0.0113	CbGeAlD
Imipramine—SLC22A3—embryo—colon cancer	0.00107	0.0108	CbGeAlD
Imipramine—KCND3—liver—colon cancer	0.00103	0.0104	CbGeAlD
Imipramine—HTR2A—endothelium—colon cancer	0.001	0.0101	CbGeAlD
Imipramine—SLC22A2—digestive system—colon cancer	0.000987	0.00996	CbGeAlD
Imipramine—CYP2C18—liver—colon cancer	0.000942	0.0095	CbGeAlD
Imipramine—HTR2A—blood vessel—colon cancer	0.000927	0.00935	CbGeAlD
Imipramine—CYP3A7—liver—colon cancer	0.000896	0.00904	CbGeAlD
Imipramine—SLC22A4—renal system—colon cancer	0.000893	0.009	CbGeAlD
Imipramine—SLC22A1—renal system—colon cancer	0.00085	0.00857	CbGeAlD
Imipramine—SLC22A3—smooth muscle tissue—colon cancer	0.000844	0.00851	CbGeAlD
Imipramine—SLC22A3—renal system—colon cancer	0.000812	0.00819	CbGeAlD
Imipramine—KCND3—lymph node—colon cancer	0.000793	0.008	CbGeAlD
Imipramine—CYP3A7-CYP3A51P—liver—colon cancer	0.000762	0.00769	CbGeAlD
Imipramine—CHRM3—smooth muscle tissue—colon cancer	0.000732	0.00739	CbGeAlD
Imipramine—SLC22A4—digestive system—colon cancer	0.000732	0.00739	CbGeAlD
Imipramine—HTR7—epithelium—colon cancer	0.000723	0.0073	CbGeAlD
Imipramine—CHRM3—renal system—colon cancer	0.000705	0.00711	CbGeAlD
Imipramine—HTR1A—renal system—colon cancer	0.000702	0.00708	CbGeAlD
Imipramine—ORM1—bone marrow—colon cancer	0.000702	0.00708	CbGeAlD
Imipramine—ADRA1A—epithelium—colon cancer	0.000698	0.00704	CbGeAlD
Imipramine—HTR7—smooth muscle tissue—colon cancer	0.000697	0.00703	CbGeAlD
Imipramine—SLC22A4—bone marrow—colon cancer	0.000675	0.00681	CbGeAlD
Imipramine—HTR7—renal system—colon cancer	0.000671	0.00677	CbGeAlD
Imipramine—SLC6A4—digestive system—colon cancer	0.000648	0.00654	CbGeAlD
Imipramine—ADRA1A—renal system—colon cancer	0.000647	0.00653	CbGeAlD
Imipramine—SLC22A4—vagina—colon cancer	0.000646	0.00652	CbGeAlD
Imipramine—KCNH2—renal system—colon cancer	0.000625	0.00631	CbGeAlD
Imipramine—SLC22A1—vagina—colon cancer	0.000616	0.00621	CbGeAlD
Imipramine—ABCB1—blood vessel—colon cancer	0.000607	0.00613	CbGeAlD
Imipramine—SLC22A3—vagina—colon cancer	0.000588	0.00594	CbGeAlD
Imipramine—CHRM3—digestive system—colon cancer	0.000578	0.00583	CbGeAlD
Imipramine—ORM1—liver—colon cancer	0.000567	0.00572	CbGeAlD
Imipramine—HTR2A—embryo—colon cancer	0.000553	0.00558	CbGeAlD
Imipramine—HTR7—digestive system—colon cancer	0.00055	0.00555	CbGeAlD
Imipramine—HRH1—epithelium—colon cancer	0.00054	0.00545	CbGeAlD
Imipramine—CYP2C19—digestive system—colon cancer	0.000537	0.00542	CbGeAlD
Imipramine—ADRA1A—lymphoid tissue—colon cancer	0.000537	0.00542	CbGeAlD
Imipramine—CYP1A2—renal system—colon cancer	0.000535	0.0054	CbGeAlD
Imipramine—HRH1—smooth muscle tissue—colon cancer	0.00052	0.00525	CbGeAlD
Imipramine—SLC22A1—liver—colon cancer	0.000519	0.00524	CbGeAlD
Imipramine—CYP2B6—renal system—colon cancer	0.000513	0.00517	CbGeAlD
Imipramine—SLC22A3—liver—colon cancer	0.000496	0.00501	CbGeAlD
Imipramine—CYP2E1—renal system—colon cancer	0.000481	0.00486	CbGeAlD
Imipramine—CYP2C19—vagina—colon cancer	0.000475	0.00479	CbGeAlD
Imipramine—KCNH2—bone marrow—colon cancer	0.000473	0.00477	CbGeAlD
Imipramine—Angiopathy—Vincristine—colon cancer	0.00047	0.00329	CcSEcCtD
Imipramine—Cardiac disorder—Irinotecan—colon cancer	0.000468	0.00328	CcSEcCtD
Imipramine—Flushing—Irinotecan—colon cancer	0.000468	0.00328	CcSEcCtD
Imipramine—Mediastinal disorder—Vincristine—colon cancer	0.000467	0.00327	CcSEcCtD
Imipramine—Urinary retention—Capecitabine—colon cancer	0.000464	0.00325	CcSEcCtD
Imipramine—Mood swings—Capecitabine—colon cancer	0.000462	0.00323	CcSEcCtD
Imipramine—Ataxia—Capecitabine—colon cancer	0.000459	0.00321	CcSEcCtD
Imipramine—Alopecia—Vincristine—colon cancer	0.000458	0.0032	CcSEcCtD
Imipramine—Angiopathy—Irinotecan—colon cancer	0.000458	0.0032	CcSEcCtD
Imipramine—Immune system disorder—Irinotecan—colon cancer	0.000456	0.00319	CcSEcCtD
Imipramine—Mediastinal disorder—Irinotecan—colon cancer	0.000455	0.00318	CcSEcCtD
Imipramine—Mental disorder—Vincristine—colon cancer	0.000454	0.00317	CcSEcCtD
Imipramine—KCNH2—vagina—colon cancer	0.000453	0.00457	CbGeAlD
Imipramine—HTR2A—epithelium—colon cancer	0.000451	0.00455	CbGeAlD
Imipramine—Arrhythmia—Irinotecan—colon cancer	0.000451	0.00315	CcSEcCtD
Imipramine—Liver function test abnormal—Capecitabine—colon cancer	0.000451	0.00315	CcSEcCtD
Imipramine—Gynaecomastia—Methotrexate—colon cancer	0.000448	0.00313	CcSEcCtD
Imipramine—Alopecia—Irinotecan—colon cancer	0.000446	0.00312	CcSEcCtD
Imipramine—Orthostatic hypotension—Capecitabine—colon cancer	0.000446	0.00312	CcSEcCtD
Imipramine—Breast disorder—Capecitabine—colon cancer	0.000441	0.00309	CcSEcCtD
Imipramine—CYP1A2—digestive system—colon cancer	0.000439	0.00443	CbGeAlD
Imipramine—ORM1—lymph node—colon cancer	0.000435	0.00439	CbGeAlD
Imipramine—HTR2A—smooth muscle tissue—colon cancer	0.000435	0.00438	CbGeAlD
Imipramine—Arrhythmia—Fluorouracil—colon cancer	0.000432	0.00302	CcSEcCtD
Imipramine—Alopecia—Fluorouracil—colon cancer	0.000427	0.00299	CcSEcCtD
Imipramine—CYP2B6—lymphoid tissue—colon cancer	0.000426	0.0043	CbGeAlD
Imipramine—CYP2B6—digestive system—colon cancer	0.000421	0.00424	CbGeAlD
Imipramine—HTR2A—renal system—colon cancer	0.000418	0.00422	CbGeAlD
Imipramine—SLC22A4—lymph node—colon cancer	0.000418	0.00422	CbGeAlD
Imipramine—Agitation—Vincristine—colon cancer	0.000414	0.0029	CcSEcCtD
Imipramine—HRH1—digestive system—colon cancer	0.000411	0.00414	CbGeAlD
Imipramine—HTR7—liver—colon cancer	0.00041	0.00414	CbGeAlD
Imipramine—Ill-defined disorder—Irinotecan—colon cancer	0.000407	0.00285	CcSEcCtD
Imipramine—Leukopenia—Vincristine—colon cancer	0.000404	0.00282	CcSEcCtD
Imipramine—Pancytopenia—Capecitabine—colon cancer	0.000401	0.0028	CcSEcCtD
Imipramine—CYP2C19—liver—colon cancer	0.0004	0.00404	CbGeAlD
Imipramine—CYP2E1—lymphoid tissue—colon cancer	0.0004	0.00403	CbGeAlD
Imipramine—Vision blurred—Fluorouracil—colon cancer	0.000396	0.00277	CcSEcCtD
Imipramine—Malaise—Irinotecan—colon cancer	0.000396	0.00277	CcSEcCtD
Imipramine—ADRA1A—liver—colon cancer	0.000395	0.00399	CbGeAlD
Imipramine—CYP2E1—digestive system—colon cancer	0.000395	0.00398	CbGeAlD
Imipramine—Syncope—Irinotecan—colon cancer	0.000394	0.00275	CcSEcCtD
Imipramine—Leukopenia—Irinotecan—colon cancer	0.000393	0.00275	CcSEcCtD
Imipramine—Convulsion—Vincristine—colon cancer	0.000391	0.00273	CcSEcCtD
Imipramine—Hypertension—Vincristine—colon cancer	0.000389	0.00272	CcSEcCtD
Imipramine—CYP3A4—renal system—colon cancer	0.000387	0.00391	CbGeAlD
Imipramine—Loss of consciousness—Irinotecan—colon cancer	0.000386	0.0027	CcSEcCtD
Imipramine—Photosensitivity reaction—Capecitabine—colon cancer	0.000385	0.00269	CcSEcCtD
Imipramine—Weight increased—Capecitabine—colon cancer	0.000384	0.00269	CcSEcCtD
Imipramine—Weight decreased—Capecitabine—colon cancer	0.000382	0.00267	CcSEcCtD
Imipramine—CYP2D6—renal system—colon cancer	0.000381	0.00385	CbGeAlD
Imipramine—SLC22A3—lymph node—colon cancer	0.000381	0.00384	CbGeAlD
Imipramine—Hypertension—Irinotecan—colon cancer	0.000379	0.00265	CcSEcCtD
Imipramine—Leukopenia—Fluorouracil—colon cancer	0.000376	0.00263	CcSEcCtD
Imipramine—Infestation—Capecitabine—colon cancer	0.000376	0.00263	CcSEcCtD
Imipramine—Infestation NOS—Capecitabine—colon cancer	0.000376	0.00263	CcSEcCtD
Imipramine—CYP2B6—vagina—colon cancer	0.000372	0.00375	CbGeAlD
Imipramine—Acute coronary syndrome—Capecitabine—colon cancer	0.000371	0.00259	CcSEcCtD
Imipramine—Cerebrovascular accident—Methotrexate—colon cancer	0.000371	0.00259	CcSEcCtD
Imipramine—Discomfort—Irinotecan—colon cancer	0.000369	0.00258	CcSEcCtD
Imipramine—Myocardial infarction—Capecitabine—colon cancer	0.000369	0.00258	CcSEcCtD
Imipramine—Neuropathy peripheral—Capecitabine—colon cancer	0.000369	0.00258	CcSEcCtD
Imipramine—Oedema—Vincristine—colon cancer	0.000368	0.00257	CcSEcCtD
Imipramine—Anaphylactic shock—Vincristine—colon cancer	0.000368	0.00257	CcSEcCtD
Imipramine—Jaundice—Capecitabine—colon cancer	0.000367	0.00256	CcSEcCtD
Imipramine—Stomatitis—Capecitabine—colon cancer	0.000367	0.00256	CcSEcCtD
Imipramine—Infection—Vincristine—colon cancer	0.000366	0.00256	CcSEcCtD
Imipramine—Convulsion—Fluorouracil—colon cancer	0.000364	0.00255	CcSEcCtD
Imipramine—HRH1—vagina—colon cancer	0.000363	0.00366	CbGeAlD
Imipramine—ABCB1—embryo—colon cancer	0.000362	0.00365	CbGeAlD
Imipramine—Confusional state—Irinotecan—colon cancer	0.000361	0.00253	CcSEcCtD
Imipramine—Nervous system disorder—Vincristine—colon cancer	0.000361	0.00252	CcSEcCtD
Imipramine—Thrombocytopenia—Vincristine—colon cancer	0.00036	0.00252	CcSEcCtD
Imipramine—Oedema—Irinotecan—colon cancer	0.000358	0.00251	CcSEcCtD
Imipramine—Anaphylactic shock—Irinotecan—colon cancer	0.000358	0.00251	CcSEcCtD
Imipramine—Infection—Irinotecan—colon cancer	0.000356	0.00249	CcSEcCtD
Imipramine—Hyperhidrosis—Vincristine—colon cancer	0.000356	0.00249	CcSEcCtD
Imipramine—Hepatobiliary disease—Capecitabine—colon cancer	0.000356	0.00249	CcSEcCtD
Imipramine—Discomfort—Fluorouracil—colon cancer	0.000354	0.00247	CcSEcCtD
Imipramine—Shock—Irinotecan—colon cancer	0.000353	0.00247	CcSEcCtD
Imipramine—Nervous system disorder—Irinotecan—colon cancer	0.000351	0.00246	CcSEcCtD
Imipramine—Agranulocytosis—Capecitabine—colon cancer	0.000351	0.00246	CcSEcCtD
Imipramine—Thrombocytopenia—Irinotecan—colon cancer	0.000351	0.00245	CcSEcCtD
Imipramine—Anorexia—Vincristine—colon cancer	0.000351	0.00245	CcSEcCtD
Imipramine—Hyperhidrosis—Irinotecan—colon cancer	0.000346	0.00242	CcSEcCtD
Imipramine—Confusional state—Fluorouracil—colon cancer	0.000346	0.00242	CcSEcCtD
Imipramine—Mood swings—Methotrexate—colon cancer	0.000344	0.00241	CcSEcCtD
Imipramine—Oedema—Fluorouracil—colon cancer	0.000343	0.0024	CcSEcCtD
Imipramine—Anaphylactic shock—Fluorouracil—colon cancer	0.000343	0.0024	CcSEcCtD
Imipramine—HTR2A—digestive system—colon cancer	0.000343	0.00346	CbGeAlD
Imipramine—Anorexia—Irinotecan—colon cancer	0.000342	0.00239	CcSEcCtD
Imipramine—Ataxia—Methotrexate—colon cancer	0.000342	0.00239	CcSEcCtD
Imipramine—Infection—Fluorouracil—colon cancer	0.000341	0.00239	CcSEcCtD
Imipramine—Hepatitis—Capecitabine—colon cancer	0.000338	0.00236	CcSEcCtD
Imipramine—Nervous system disorder—Fluorouracil—colon cancer	0.000337	0.00235	CcSEcCtD
Imipramine—Thrombocytopenia—Fluorouracil—colon cancer	0.000336	0.00235	CcSEcCtD
Imipramine—Hypoaesthesia—Capecitabine—colon cancer	0.000336	0.00235	CcSEcCtD
Imipramine—Liver function test abnormal—Methotrexate—colon cancer	0.000335	0.00235	CcSEcCtD
Imipramine—Tachycardia—Fluorouracil—colon cancer	0.000335	0.00234	CcSEcCtD
Imipramine—Urinary tract disorder—Capecitabine—colon cancer	0.000333	0.00233	CcSEcCtD
Imipramine—Insomnia—Vincristine—colon cancer	0.000333	0.00233	CcSEcCtD
Imipramine—Urethral disorder—Capecitabine—colon cancer	0.000331	0.00232	CcSEcCtD
Imipramine—Paraesthesia—Vincristine—colon cancer	0.00033	0.00231	CcSEcCtD
Imipramine—Breast disorder—Methotrexate—colon cancer	0.000328	0.0023	CcSEcCtD
Imipramine—Anorexia—Fluorouracil—colon cancer	0.000327	0.00229	CcSEcCtD
Imipramine—CYP1A2—liver—colon cancer	0.000327	0.0033	CbGeAlD
Imipramine—SLC6A2—lymph node—colon cancer	0.000326	0.00329	CbGeAlD
Imipramine—Insomnia—Irinotecan—colon cancer	0.000324	0.00227	CcSEcCtD
Imipramine—Paraesthesia—Irinotecan—colon cancer	0.000322	0.00225	CcSEcCtD
Imipramine—Decreased appetite—Vincristine—colon cancer	0.00032	0.00224	CcSEcCtD
Imipramine—Somnolence—Irinotecan—colon cancer	0.000319	0.00223	CcSEcCtD
Imipramine—Gastrointestinal disorder—Vincristine—colon cancer	0.000318	0.00222	CcSEcCtD
Imipramine—CYP3A4—digestive system—colon cancer	0.000318	0.0032	CbGeAlD
Imipramine—Fatigue—Vincristine—colon cancer	0.000317	0.00222	CcSEcCtD
Imipramine—Eye disorder—Capecitabine—colon cancer	0.000316	0.00221	CcSEcCtD
Imipramine—Dyspepsia—Irinotecan—colon cancer	0.000315	0.00221	CcSEcCtD
Imipramine—Tinnitus—Capecitabine—colon cancer	0.000315	0.0022	CcSEcCtD
Imipramine—Constipation—Vincristine—colon cancer	0.000315	0.0022	CcSEcCtD
Imipramine—CYP2B6—liver—colon cancer	0.000313	0.00316	CbGeAlD
Imipramine—Cardiac disorder—Capecitabine—colon cancer	0.000313	0.00219	CcSEcCtD
Imipramine—Flushing—Capecitabine—colon cancer	0.000313	0.00219	CcSEcCtD
Imipramine—CYP2D6—digestive system—colon cancer	0.000313	0.00315	CbGeAlD
Imipramine—Decreased appetite—Irinotecan—colon cancer	0.000312	0.00218	CcSEcCtD
Imipramine—Eosinophilia—Methotrexate—colon cancer	0.000311	0.00217	CcSEcCtD
Imipramine—Insomnia—Fluorouracil—colon cancer	0.00031	0.00217	CcSEcCtD
Imipramine—Gastrointestinal disorder—Irinotecan—colon cancer	0.000309	0.00216	CcSEcCtD
Imipramine—Fatigue—Irinotecan—colon cancer	0.000309	0.00216	CcSEcCtD
Imipramine—Paraesthesia—Fluorouracil—colon cancer	0.000308	0.00216	CcSEcCtD
Imipramine—Constipation—Irinotecan—colon cancer	0.000306	0.00214	CcSEcCtD
Imipramine—Angiopathy—Capecitabine—colon cancer	0.000306	0.00214	CcSEcCtD
Imipramine—Somnolence—Fluorouracil—colon cancer	0.000305	0.00213	CcSEcCtD
Imipramine—Immune system disorder—Capecitabine—colon cancer	0.000305	0.00213	CcSEcCtD
Imipramine—Mediastinal disorder—Capecitabine—colon cancer	0.000304	0.00213	CcSEcCtD
Imipramine—HTR2A—vagina—colon cancer	0.000303	0.00306	CbGeAlD
Imipramine—Dyspepsia—Fluorouracil—colon cancer	0.000302	0.00211	CcSEcCtD
Imipramine—Arrhythmia—Capecitabine—colon cancer	0.000302	0.00211	CcSEcCtD
Imipramine—Gastrointestinal pain—Vincristine—colon cancer	0.000301	0.00211	CcSEcCtD
Imipramine—Decreased appetite—Fluorouracil—colon cancer	0.000298	0.00209	CcSEcCtD
Imipramine—Alopecia—Capecitabine—colon cancer	0.000298	0.00209	CcSEcCtD
Imipramine—Pancytopenia—Methotrexate—colon cancer	0.000298	0.00209	CcSEcCtD
Imipramine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000296	0.00207	CcSEcCtD
Imipramine—Mental disorder—Capecitabine—colon cancer	0.000296	0.00207	CcSEcCtD
Imipramine—ABCB1—epithelium—colon cancer	0.000296	0.00298	CbGeAlD
Imipramine—Feeling abnormal—Irinotecan—colon cancer	0.000295	0.00207	CcSEcCtD
Imipramine—CYP2E1—liver—colon cancer	0.000294	0.00297	CbGeAlD
Imipramine—Malnutrition—Capecitabine—colon cancer	0.000294	0.00206	CcSEcCtD
Imipramine—Gastrointestinal pain—Irinotecan—colon cancer	0.000293	0.00205	CcSEcCtD
Imipramine—KCNH2—lymph node—colon cancer	0.000293	0.00295	CbGeAlD
Imipramine—Abdominal pain—Vincristine—colon cancer	0.000291	0.00204	CcSEcCtD
Imipramine—Body temperature increased—Vincristine—colon cancer	0.000291	0.00204	CcSEcCtD
Imipramine—Erectile dysfunction—Methotrexate—colon cancer	0.000289	0.00202	CcSEcCtD
Imipramine—Dysgeusia—Capecitabine—colon cancer	0.000288	0.00201	CcSEcCtD
Imipramine—Photosensitivity reaction—Methotrexate—colon cancer	0.000287	0.00201	CcSEcCtD
Imipramine—Abdominal pain—Irinotecan—colon cancer	0.000283	0.00198	CcSEcCtD
Imipramine—Body temperature increased—Irinotecan—colon cancer	0.000283	0.00198	CcSEcCtD
Imipramine—Feeling abnormal—Fluorouracil—colon cancer	0.000283	0.00198	CcSEcCtD
Imipramine—Infestation NOS—Methotrexate—colon cancer	0.00028	0.00196	CcSEcCtD
Imipramine—Infestation—Methotrexate—colon cancer	0.00028	0.00196	CcSEcCtD
Imipramine—Drowsiness—Methotrexate—colon cancer	0.00028	0.00196	CcSEcCtD
Imipramine—Vision blurred—Capecitabine—colon cancer	0.000277	0.00194	CcSEcCtD
Imipramine—Tremor—Capecitabine—colon cancer	0.000275	0.00193	CcSEcCtD
Imipramine—ABCB1—renal system—colon cancer	0.000274	0.00277	CbGeAlD
Imipramine—Stomatitis—Methotrexate—colon cancer	0.000273	0.00191	CcSEcCtD
Imipramine—Ill-defined disorder—Capecitabine—colon cancer	0.000273	0.00191	CcSEcCtD
Imipramine—Urticaria—Fluorouracil—colon cancer	0.000273	0.00191	CcSEcCtD
Imipramine—Body temperature increased—Fluorouracil—colon cancer	0.000271	0.0019	CcSEcCtD
Imipramine—Malaise—Capecitabine—colon cancer	0.000265	0.00185	CcSEcCtD
Imipramine—Hepatobiliary disease—Methotrexate—colon cancer	0.000265	0.00185	CcSEcCtD
Imipramine—Asthenia—Vincristine—colon cancer	0.000264	0.00185	CcSEcCtD
Imipramine—Syncope—Capecitabine—colon cancer	0.000264	0.00184	CcSEcCtD
Imipramine—Leukopenia—Capecitabine—colon cancer	0.000263	0.00184	CcSEcCtD
Imipramine—Agranulocytosis—Methotrexate—colon cancer	0.000261	0.00183	CcSEcCtD
Imipramine—Palpitations—Capecitabine—colon cancer	0.00026	0.00182	CcSEcCtD
Imipramine—Loss of consciousness—Capecitabine—colon cancer	0.000258	0.00181	CcSEcCtD
Imipramine—Asthenia—Irinotecan—colon cancer	0.000257	0.0018	CcSEcCtD
Imipramine—HTR2A—liver—colon cancer	0.000256	0.00258	CbGeAlD
Imipramine—Hypertension—Capecitabine—colon cancer	0.000254	0.00178	CcSEcCtD
Imipramine—Diarrhoea—Vincristine—colon cancer	0.000252	0.00176	CcSEcCtD
Imipramine—Hepatitis—Methotrexate—colon cancer	0.000251	0.00176	CcSEcCtD
Imipramine—Anxiety—Capecitabine—colon cancer	0.000249	0.00174	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000249	0.00174	CcSEcCtD
Imipramine—Urinary tract disorder—Methotrexate—colon cancer	0.000248	0.00174	CcSEcCtD
Imipramine—Discomfort—Capecitabine—colon cancer	0.000247	0.00173	CcSEcCtD
Imipramine—Urethral disorder—Methotrexate—colon cancer	0.000246	0.00172	CcSEcCtD
Imipramine—Diarrhoea—Irinotecan—colon cancer	0.000245	0.00172	CcSEcCtD
Imipramine—Dry mouth—Capecitabine—colon cancer	0.000245	0.00171	CcSEcCtD
Imipramine—Dizziness—Vincristine—colon cancer	0.000243	0.0017	CcSEcCtD
Imipramine—Pruritus—Fluorouracil—colon cancer	0.000243	0.0017	CcSEcCtD
Imipramine—Confusional state—Capecitabine—colon cancer	0.000242	0.00169	CcSEcCtD
Imipramine—Oedema—Capecitabine—colon cancer	0.00024	0.00168	CcSEcCtD
Imipramine—Infection—Capecitabine—colon cancer	0.000238	0.00167	CcSEcCtD
Imipramine—Dizziness—Irinotecan—colon cancer	0.000237	0.00166	CcSEcCtD
Imipramine—CYP3A4—liver—colon cancer	0.000237	0.00239	CbGeAlD
Imipramine—Shock—Capecitabine—colon cancer	0.000236	0.00165	CcSEcCtD
Imipramine—Nervous system disorder—Capecitabine—colon cancer	0.000235	0.00165	CcSEcCtD
Imipramine—Eye disorder—Methotrexate—colon cancer	0.000235	0.00164	CcSEcCtD
Imipramine—Diarrhoea—Fluorouracil—colon cancer	0.000235	0.00164	CcSEcCtD
Imipramine—Thrombocytopenia—Capecitabine—colon cancer	0.000235	0.00164	CcSEcCtD
Imipramine—HRH1—lymph node—colon cancer	0.000235	0.00237	CbGeAlD
Imipramine—Tinnitus—Methotrexate—colon cancer	0.000234	0.00164	CcSEcCtD
Imipramine—Tachycardia—Capecitabine—colon cancer	0.000234	0.00164	CcSEcCtD
Imipramine—Vomiting—Vincristine—colon cancer	0.000234	0.00164	CcSEcCtD
Imipramine—Cardiac disorder—Methotrexate—colon cancer	0.000233	0.00163	CcSEcCtD
Imipramine—Skin disorder—Capecitabine—colon cancer	0.000233	0.00163	CcSEcCtD
Imipramine—CYP2D6—liver—colon cancer	0.000233	0.00235	CbGeAlD
Imipramine—Rash—Vincristine—colon cancer	0.000232	0.00162	CcSEcCtD
Imipramine—Hyperhidrosis—Capecitabine—colon cancer	0.000232	0.00162	CcSEcCtD
Imipramine—Dermatitis—Vincristine—colon cancer	0.000232	0.00162	CcSEcCtD
Imipramine—Headache—Vincristine—colon cancer	0.000231	0.00161	CcSEcCtD
Imipramine—Epinastine—ABCB1—colon cancer	0.000229	0.158	CrCbGaD
Imipramine—Anorexia—Capecitabine—colon cancer	0.000229	0.0016	CcSEcCtD
Imipramine—Angiopathy—Methotrexate—colon cancer	0.000228	0.0016	CcSEcCtD
Imipramine—Vomiting—Irinotecan—colon cancer	0.000228	0.00159	CcSEcCtD
Imipramine—ABCB1—lymphoid tissue—colon cancer	0.000228	0.0023	CbGeAlD
Imipramine—Immune system disorder—Methotrexate—colon cancer	0.000227	0.00159	CcSEcCtD
Imipramine—Dizziness—Fluorouracil—colon cancer	0.000227	0.00159	CcSEcCtD
Imipramine—Mediastinal disorder—Methotrexate—colon cancer	0.000227	0.00158	CcSEcCtD
Imipramine—Rash—Irinotecan—colon cancer	0.000226	0.00158	CcSEcCtD
Imipramine—Dermatitis—Irinotecan—colon cancer	0.000226	0.00158	CcSEcCtD
Imipramine—ABCB1—digestive system—colon cancer	0.000225	0.00227	CbGeAlD
Imipramine—Headache—Irinotecan—colon cancer	0.000225	0.00157	CcSEcCtD
Imipramine—Alopecia—Methotrexate—colon cancer	0.000222	0.00155	CcSEcCtD
Imipramine—Mental disorder—Methotrexate—colon cancer	0.00022	0.00154	CcSEcCtD
Imipramine—Malnutrition—Methotrexate—colon cancer	0.000219	0.00153	CcSEcCtD
Imipramine—Nausea—Vincristine—colon cancer	0.000219	0.00153	CcSEcCtD
Imipramine—Vomiting—Fluorouracil—colon cancer	0.000218	0.00153	CcSEcCtD
Imipramine—Insomnia—Capecitabine—colon cancer	0.000217	0.00152	CcSEcCtD
Imipramine—Rash—Fluorouracil—colon cancer	0.000216	0.00151	CcSEcCtD
Imipramine—Dermatitis—Fluorouracil—colon cancer	0.000216	0.00151	CcSEcCtD
Imipramine—Paraesthesia—Capecitabine—colon cancer	0.000215	0.00151	CcSEcCtD
Imipramine—Headache—Fluorouracil—colon cancer	0.000215	0.0015	CcSEcCtD
Imipramine—Dysgeusia—Methotrexate—colon cancer	0.000214	0.0015	CcSEcCtD
Imipramine—Nausea—Irinotecan—colon cancer	0.000213	0.00149	CcSEcCtD
Imipramine—Dyspepsia—Capecitabine—colon cancer	0.000211	0.00148	CcSEcCtD
Imipramine—Decreased appetite—Capecitabine—colon cancer	0.000209	0.00146	CcSEcCtD
Imipramine—ABCB1—bone marrow—colon cancer	0.000207	0.00209	CbGeAlD
Imipramine—Gastrointestinal disorder—Capecitabine—colon cancer	0.000207	0.00145	CcSEcCtD
Imipramine—Fatigue—Capecitabine—colon cancer	0.000207	0.00145	CcSEcCtD
Imipramine—Vision blurred—Methotrexate—colon cancer	0.000206	0.00144	CcSEcCtD
Imipramine—Constipation—Capecitabine—colon cancer	0.000205	0.00143	CcSEcCtD
Imipramine—Nausea—Fluorouracil—colon cancer	0.000204	0.00143	CcSEcCtD
Imipramine—Ill-defined disorder—Methotrexate—colon cancer	0.000203	0.00142	CcSEcCtD
Imipramine—ABCB1—vagina—colon cancer	0.000199	0.002	CbGeAlD
Imipramine—Feeling abnormal—Capecitabine—colon cancer	0.000198	0.00138	CcSEcCtD
Imipramine—Malaise—Methotrexate—colon cancer	0.000197	0.00138	CcSEcCtD
Imipramine—Maprotiline—ABCB1—colon cancer	0.000197	0.136	CrCbGaD
Imipramine—Gastrointestinal pain—Capecitabine—colon cancer	0.000196	0.00137	CcSEcCtD
Imipramine—Leukopenia—Methotrexate—colon cancer	0.000196	0.00137	CcSEcCtD
Imipramine—Urticaria—Capecitabine—colon cancer	0.000191	0.00133	CcSEcCtD
Imipramine—Body temperature increased—Capecitabine—colon cancer	0.00019	0.00133	CcSEcCtD
Imipramine—Abdominal pain—Capecitabine—colon cancer	0.00019	0.00133	CcSEcCtD
Imipramine—Convulsion—Methotrexate—colon cancer	0.00019	0.00133	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000185	0.00129	CcSEcCtD
Imipramine—Discomfort—Methotrexate—colon cancer	0.000184	0.00129	CcSEcCtD
Imipramine—Confusional state—Methotrexate—colon cancer	0.00018	0.00126	CcSEcCtD
Imipramine—Anaphylactic shock—Methotrexate—colon cancer	0.000179	0.00125	CcSEcCtD
Imipramine—Infection—Methotrexate—colon cancer	0.000177	0.00124	CcSEcCtD
Imipramine—Nervous system disorder—Methotrexate—colon cancer	0.000175	0.00122	CcSEcCtD
Imipramine—Thrombocytopenia—Methotrexate—colon cancer	0.000175	0.00122	CcSEcCtD
Imipramine—Skin disorder—Methotrexate—colon cancer	0.000173	0.00121	CcSEcCtD
Imipramine—Hyperhidrosis—Methotrexate—colon cancer	0.000173	0.00121	CcSEcCtD
Imipramine—Triflupromazine—ABCB1—colon cancer	0.000172	0.119	CrCbGaD
Imipramine—Asthenia—Capecitabine—colon cancer	0.000172	0.0012	CcSEcCtD
Imipramine—Anorexia—Methotrexate—colon cancer	0.00017	0.00119	CcSEcCtD
Imipramine—Pruritus—Capecitabine—colon cancer	0.00017	0.00119	CcSEcCtD
Imipramine—ABCB1—liver—colon cancer	0.000168	0.00169	CbGeAlD
Imipramine—Diarrhoea—Capecitabine—colon cancer	0.000164	0.00115	CcSEcCtD
Imipramine—Insomnia—Methotrexate—colon cancer	0.000162	0.00113	CcSEcCtD
Imipramine—Paraesthesia—Methotrexate—colon cancer	0.00016	0.00112	CcSEcCtD
Imipramine—Somnolence—Methotrexate—colon cancer	0.000159	0.00111	CcSEcCtD
Imipramine—Dizziness—Capecitabine—colon cancer	0.000159	0.00111	CcSEcCtD
Imipramine—Dyspepsia—Methotrexate—colon cancer	0.000157	0.0011	CcSEcCtD
Imipramine—Decreased appetite—Methotrexate—colon cancer	0.000155	0.00109	CcSEcCtD
Imipramine—Gastrointestinal disorder—Methotrexate—colon cancer	0.000154	0.00108	CcSEcCtD
Imipramine—Fatigue—Methotrexate—colon cancer	0.000154	0.00108	CcSEcCtD
Imipramine—Vomiting—Capecitabine—colon cancer	0.000153	0.00107	CcSEcCtD
Imipramine—Rash—Capecitabine—colon cancer	0.000151	0.00106	CcSEcCtD
Imipramine—Dermatitis—Capecitabine—colon cancer	0.000151	0.00106	CcSEcCtD
Imipramine—Headache—Capecitabine—colon cancer	0.00015	0.00105	CcSEcCtD
Imipramine—Feeling abnormal—Methotrexate—colon cancer	0.000147	0.00103	CcSEcCtD
Imipramine—Gastrointestinal pain—Methotrexate—colon cancer	0.000146	0.00102	CcSEcCtD
Imipramine—Carbamazepine—ABCB1—colon cancer	0.000144	0.0991	CrCbGaD
Imipramine—Nausea—Capecitabine—colon cancer	0.000142	0.000997	CcSEcCtD
Imipramine—Urticaria—Methotrexate—colon cancer	0.000142	0.000992	CcSEcCtD
Imipramine—Abdominal pain—Methotrexate—colon cancer	0.000141	0.000987	CcSEcCtD
Imipramine—Body temperature increased—Methotrexate—colon cancer	0.000141	0.000987	CcSEcCtD
Imipramine—ABCB1—lymph node—colon cancer	0.000128	0.0013	CbGeAlD
Imipramine—Asthenia—Methotrexate—colon cancer	0.000128	0.000896	CcSEcCtD
Imipramine—Pruritus—Methotrexate—colon cancer	0.000126	0.000884	CcSEcCtD
Imipramine—Diarrhoea—Methotrexate—colon cancer	0.000122	0.000855	CcSEcCtD
Imipramine—Clomipramine—ABCB1—colon cancer	0.000121	0.0835	CrCbGaD
Imipramine—Dizziness—Methotrexate—colon cancer	0.000118	0.000826	CcSEcCtD
Imipramine—Vomiting—Methotrexate—colon cancer	0.000114	0.000794	CcSEcCtD
Imipramine—Rash—Methotrexate—colon cancer	0.000113	0.000788	CcSEcCtD
Imipramine—Dermatitis—Methotrexate—colon cancer	0.000112	0.000787	CcSEcCtD
Imipramine—Headache—Methotrexate—colon cancer	0.000112	0.000783	CcSEcCtD
Imipramine—Trimipramine—ABCB1—colon cancer	0.000111	0.0768	CrCbGaD
Imipramine—Promethazine—ABCB1—colon cancer	0.000107	0.074	CrCbGaD
Imipramine—Doxepin—ABCB1—colon cancer	0.000106	0.0732	CrCbGaD
Imipramine—Nausea—Methotrexate—colon cancer	0.000106	0.000742	CcSEcCtD
Imipramine—Desipramine—ABCB1—colon cancer	9.75e-05	0.0672	CrCbGaD
Imipramine—Chlorpromazine—ABCB1—colon cancer	8.31e-05	0.0573	CrCbGaD
Imipramine—Amitriptyline—ABCB1—colon cancer	8.22e-05	0.0566	CrCbGaD
Imipramine—CYP2B6—Metabolism—PTGS2—colon cancer	2.69e-06	0.000149	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—PIK3CA—colon cancer	2.69e-06	0.000149	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CDKN1A—colon cancer	2.67e-06	0.000148	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CDKN1A—colon cancer	2.65e-06	0.000147	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—EGFR—colon cancer	2.64e-06	0.000146	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—PTGS2—colon cancer	2.63e-06	0.000146	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CCND1—colon cancer	2.63e-06	0.000146	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—KRAS—colon cancer	2.6e-06	0.000144	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CTNNB1—colon cancer	2.6e-06	0.000144	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—EP300—colon cancer	2.6e-06	0.000144	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—AKT1—colon cancer	2.6e-06	0.000144	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PPARG—colon cancer	2.58e-06	0.000143	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—AKT1—colon cancer	2.58e-06	0.000143	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—HRAS—colon cancer	2.58e-06	0.000143	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—HRAS—colon cancer	2.54e-06	0.000141	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CDKN1A—colon cancer	2.54e-06	0.000141	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—EP300—colon cancer	2.54e-06	0.000141	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—MYC—colon cancer	2.54e-06	0.000141	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—PIK3CA—colon cancer	2.54e-06	0.000141	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—HRAS—colon cancer	2.53e-06	0.000141	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—PIK3CA—colon cancer	2.53e-06	0.000141	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—TGFB1—colon cancer	2.53e-06	0.00014	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—HRAS—colon cancer	2.53e-06	0.00014	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—EP300—colon cancer	2.52e-06	0.00014	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PPARG—colon cancer	2.52e-06	0.00014	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—HRAS—colon cancer	2.52e-06	0.00014	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—AKT1—colon cancer	2.51e-06	0.000139	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—HRAS—colon cancer	2.49e-06	0.000138	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—KRAS—colon cancer	2.49e-06	0.000138	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—HRAS—colon cancer	2.49e-06	0.000138	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CASP3—colon cancer	2.49e-06	0.000138	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—EGFR—colon cancer	2.48e-06	0.000138	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—AKT1—colon cancer	2.47e-06	0.000137	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—AKT1—colon cancer	2.47e-06	0.000137	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—SRC—colon cancer	2.47e-06	0.000137	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—AKT1—colon cancer	2.46e-06	0.000137	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—AKT1—colon cancer	2.46e-06	0.000136	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—SRC—colon cancer	2.46e-06	0.000136	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—TP53—colon cancer	2.45e-06	0.000136	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—TP53—colon cancer	2.45e-06	0.000136	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—AKT1—colon cancer	2.45e-06	0.000136	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CASP3—colon cancer	2.45e-06	0.000136	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CASP3—colon cancer	2.44e-06	0.000135	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CASP3—colon cancer	2.43e-06	0.000135	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CASP3—colon cancer	2.43e-06	0.000135	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—AKT1—colon cancer	2.43e-06	0.000134	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CCND1—colon cancer	2.42e-06	0.000134	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—AKT1—colon cancer	2.42e-06	0.000134	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—EP300—colon cancer	2.42e-06	0.000134	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—VEGFA—colon cancer	2.4e-06	0.000133	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CASP3—colon cancer	2.4e-06	0.000133	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CTNNB1—colon cancer	2.4e-06	0.000133	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CASP3—colon cancer	2.4e-06	0.000133	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—PIK3CA—colon cancer	2.39e-06	0.000133	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—VEGFA—colon cancer	2.39e-06	0.000133	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CCND1—colon cancer	2.38e-06	0.000132	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CCND1—colon cancer	2.38e-06	0.000132	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PPARG—colon cancer	2.38e-06	0.000132	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—NRAS—colon cancer	2.37e-06	0.000132	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CCND1—colon cancer	2.37e-06	0.000131	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—NRAS—colon cancer	2.36e-06	0.000131	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CCND1—colon cancer	2.36e-06	0.000131	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CTNNB1—colon cancer	2.36e-06	0.000131	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CTNNB1—colon cancer	2.35e-06	0.000131	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—SRC—colon cancer	2.35e-06	0.00013	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—HRAS—colon cancer	2.35e-06	0.00013	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CTNNB1—colon cancer	2.35e-06	0.00013	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—KRAS—colon cancer	2.34e-06	0.00013	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—HRAS—colon cancer	2.34e-06	0.00013	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CDKN1A—colon cancer	2.34e-06	0.00013	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CTNNB1—colon cancer	2.34e-06	0.00013	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CCND1—colon cancer	2.34e-06	0.00013	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CCND1—colon cancer	2.33e-06	0.000129	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CTNNB1—colon cancer	2.32e-06	0.000128	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—TP53—colon cancer	2.31e-06	0.000128	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CTNNB1—colon cancer	2.31e-06	0.000128	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CDKN1A—colon cancer	2.3e-06	0.000128	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CDKN1A—colon cancer	2.3e-06	0.000128	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CDKN1A—colon cancer	2.29e-06	0.000127	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—PIK3CA—colon cancer	2.29e-06	0.000127	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—VEGFA—colon cancer	2.29e-06	0.000127	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CDKN1A—colon cancer	2.28e-06	0.000127	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—AKT1—colon cancer	2.28e-06	0.000126	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CDKN1A—colon cancer	2.26e-06	0.000125	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—NRAS—colon cancer	2.26e-06	0.000125	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CDKN1A—colon cancer	2.26e-06	0.000125	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—AKT1—colon cancer	2.24e-06	0.000124	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—AKT1—colon cancer	2.24e-06	0.000124	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—PIK3CA—colon cancer	2.24e-06	0.000124	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—EP300—colon cancer	2.24e-06	0.000124	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—PIK3CA—colon cancer	2.23e-06	0.000124	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ABCB1—colon cancer	2.23e-06	0.000124	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—AKT1—colon cancer	2.23e-06	0.000124	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—EP300—colon cancer	2.23e-06	0.000124	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—AKT1—colon cancer	2.22e-06	0.000123	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—TP53—colon cancer	2.22e-06	0.000123	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—HRAS—colon cancer	2.21e-06	0.000123	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—MYC—colon cancer	2.21e-06	0.000123	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—TGFB1—colon cancer	2.21e-06	0.000122	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—AKT1—colon cancer	2.2e-06	0.000122	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—MYC—colon cancer	2.2e-06	0.000122	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—AKT1—colon cancer	2.2e-06	0.000122	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—TGFB1—colon cancer	2.19e-06	0.000122	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—TYMS—colon cancer	2.19e-06	0.000122	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—EP300—colon cancer	2.19e-06	0.000122	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—EP300—colon cancer	2.19e-06	0.000121	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—EP300—colon cancer	2.19e-06	0.000121	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.19e-06	0.000121	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—EP300—colon cancer	2.18e-06	0.000121	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—EP300—colon cancer	2.17e-06	0.000121	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—SRC—colon cancer	2.17e-06	0.00012	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—EGFR—colon cancer	2.16e-06	0.00012	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—PIK3CA—colon cancer	2.15e-06	0.000119	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—EP300—colon cancer	2.15e-06	0.000119	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—EGFR—colon cancer	2.15e-06	0.000119	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—EP300—colon cancer	2.15e-06	0.000119	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—SRC—colon cancer	2.13e-06	0.000118	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—SRC—colon cancer	2.13e-06	0.000118	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—SRC—colon cancer	2.12e-06	0.000118	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—HRAS—colon cancer	2.12e-06	0.000118	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—SRC—colon cancer	2.11e-06	0.000117	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—VEGFA—colon cancer	2.11e-06	0.000117	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MYC—colon cancer	2.11e-06	0.000117	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—TGFB1—colon cancer	2.1e-06	0.000117	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—SRC—colon cancer	2.09e-06	0.000116	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—SRC—colon cancer	2.09e-06	0.000116	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—NRAS—colon cancer	2.08e-06	0.000116	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—TP53—colon cancer	2.08e-06	0.000116	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—PIK3CA—colon cancer	2.08e-06	0.000115	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—VEGFA—colon cancer	2.08e-06	0.000115	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—VEGFA—colon cancer	2.07e-06	0.000115	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—AKT1—colon cancer	2.07e-06	0.000115	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—AKT1—colon cancer	2.07e-06	0.000115	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—VEGFA—colon cancer	2.07e-06	0.000115	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—EGFR—colon cancer	2.06e-06	0.000114	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—VEGFA—colon cancer	2.06e-06	0.000114	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—NRAS—colon cancer	2.05e-06	0.000114	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—NRAS—colon cancer	2.05e-06	0.000114	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—KRAS—colon cancer	2.04e-06	0.000113	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—NRAS—colon cancer	2.04e-06	0.000113	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—VEGFA—colon cancer	2.04e-06	0.000113	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—NRAS—colon cancer	2.03e-06	0.000113	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—VEGFA—colon cancer	2.03e-06	0.000113	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—KRAS—colon cancer	2.03e-06	0.000113	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PTGS2—colon cancer	2.03e-06	0.000113	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—NRAS—colon cancer	2.01e-06	0.000112	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PPARG—colon cancer	2.01e-06	0.000112	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—NRAS—colon cancer	2.01e-06	0.000111	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—HRAS—colon cancer	1.99e-06	0.000111	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PTGS2—colon cancer	1.98e-06	0.00011	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—AKT1—colon cancer	1.95e-06	0.000108	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—KRAS—colon cancer	1.95e-06	0.000108	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MYC—colon cancer	1.94e-06	0.000108	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TGFB1—colon cancer	1.94e-06	0.000107	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—PIK3CA—colon cancer	1.92e-06	0.000107	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MYC—colon cancer	1.91e-06	0.000106	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MYC—colon cancer	1.91e-06	0.000106	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TGFB1—colon cancer	1.91e-06	0.000106	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TGFB1—colon cancer	1.9e-06	0.000105	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MYC—colon cancer	1.9e-06	0.000105	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—EGFR—colon cancer	1.9e-06	0.000105	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TGFB1—colon cancer	1.9e-06	0.000105	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MYC—colon cancer	1.89e-06	0.000105	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TGFB1—colon cancer	1.89e-06	0.000105	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—PIK3CA—colon cancer	1.88e-06	0.000104	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MYC—colon cancer	1.88e-06	0.000104	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—AKT1—colon cancer	1.87e-06	0.000104	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TGFB1—colon cancer	1.87e-06	0.000104	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MYC—colon cancer	1.87e-06	0.000104	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PTGS2—colon cancer	1.87e-06	0.000104	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—EGFR—colon cancer	1.87e-06	0.000104	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—PIK3CA—colon cancer	1.87e-06	0.000104	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TGFB1—colon cancer	1.87e-06	0.000104	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—EGFR—colon cancer	1.86e-06	0.000103	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—EGFR—colon cancer	1.86e-06	0.000103	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—EGFR—colon cancer	1.85e-06	0.000103	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—EGFR—colon cancer	1.83e-06	0.000102	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—EGFR—colon cancer	1.83e-06	0.000101	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—AKT1—colon cancer	1.83e-06	0.000101	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—AKT1—colon cancer	1.82e-06	0.000101	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—TP53—colon cancer	1.82e-06	0.000101	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—TP53—colon cancer	1.81e-06	0.0001	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—KRAS—colon cancer	1.79e-06	9.95e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—PIK3CA—colon cancer	1.79e-06	9.92e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—KRAS—colon cancer	1.77e-06	9.79e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—KRAS—colon cancer	1.76e-06	9.77e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—AKT1—colon cancer	1.76e-06	9.76e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—KRAS—colon cancer	1.76e-06	9.74e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—KRAS—colon cancer	1.75e-06	9.71e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—HRAS—colon cancer	1.74e-06	9.63e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—KRAS—colon cancer	1.73e-06	9.61e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—TP53—colon cancer	1.73e-06	9.59e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—KRAS—colon cancer	1.73e-06	9.59e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—HRAS—colon cancer	1.73e-06	9.58e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—AKT1—colon cancer	1.7e-06	9.43e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—EP300—colon cancer	1.69e-06	9.37e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—PIK3CA—colon cancer	1.65e-06	9.18e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—HRAS—colon cancer	1.65e-06	9.17e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—EP300—colon cancer	1.65e-06	9.15e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—PIK3CA—colon cancer	1.65e-06	9.14e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—PIK3CA—colon cancer	1.62e-06	9e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—PIK3CA—colon cancer	1.62e-06	8.99e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—PIK3CA—colon cancer	1.62e-06	8.98e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—PIK3CA—colon cancer	1.61e-06	8.95e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—PIK3CA—colon cancer	1.61e-06	8.92e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TP53—colon cancer	1.59e-06	8.84e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—PIK3CA—colon cancer	1.59e-06	8.83e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—PIK3CA—colon cancer	1.59e-06	8.81e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PTGS2—colon cancer	1.58e-06	8.78e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—AKT1—colon cancer	1.57e-06	8.71e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TP53—colon cancer	1.57e-06	8.7e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TP53—colon cancer	1.57e-06	8.68e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TP53—colon cancer	1.56e-06	8.66e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TP53—colon cancer	1.56e-06	8.63e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—EP300—colon cancer	1.55e-06	8.62e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PPARG—colon cancer	1.55e-06	8.62e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TP53—colon cancer	1.54e-06	8.54e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TP53—colon cancer	1.54e-06	8.52e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—AKT1—colon cancer	1.53e-06	8.51e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—AKT1—colon cancer	1.53e-06	8.46e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—HRAS—colon cancer	1.53e-06	8.46e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—HRAS—colon cancer	1.5e-06	8.32e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—HRAS—colon cancer	1.5e-06	8.3e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—HRAS—colon cancer	1.49e-06	8.28e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—HRAS—colon cancer	1.49e-06	8.25e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—HRAS—colon cancer	1.47e-06	8.17e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—HRAS—colon cancer	1.47e-06	8.15e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—AKT1—colon cancer	1.46e-06	8.1e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—AKT1—colon cancer	1.35e-06	7.5e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—AKT1—colon cancer	1.35e-06	7.47e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—AKT1—colon cancer	1.32e-06	7.35e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—AKT1—colon cancer	1.32e-06	7.34e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—AKT1—colon cancer	1.32e-06	7.33e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—AKT1—colon cancer	1.32e-06	7.31e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—EP300—colon cancer	1.32e-06	7.3e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—AKT1—colon cancer	1.31e-06	7.29e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—AKT1—colon cancer	1.3e-06	7.22e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—AKT1—colon cancer	1.3e-06	7.2e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PIK3CA—colon cancer	1.25e-06	6.93e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PTGS2—colon cancer	1.22e-06	6.78e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PIK3CA—colon cancer	1.22e-06	6.77e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PIK3CA—colon cancer	1.15e-06	6.38e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—AKT1—colon cancer	1.02e-06	5.66e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—EP300—colon cancer	1.02e-06	5.64e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—AKT1—colon cancer	9.97e-07	5.53e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PIK3CA—colon cancer	9.74e-07	5.4e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—AKT1—colon cancer	9.39e-07	5.21e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—AKT1—colon cancer	7.96e-07	4.41e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PIK3CA—colon cancer	7.52e-07	4.17e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—AKT1—colon cancer	6.14e-07	3.41e-05	CbGpPWpGaD
